Authors:
TODESCHINI G
TECCHIO C
MENEGHINI V
PIZZOLO G
VENERI D
ZANOTTI R
RICETTI MM
SOLERO P
APRILI F
PERONA G
Citation: G. Todeschini et al., ESTIMATED 6-YEAR EVENT-FREE SURVIVAL OF 55-PERCENT IN 60 CONSECUTIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS TREATED WITH AN INTENSIVE PHASE-II PROTOCOL BASED ON HIGH INDUCTION DOSE OF DAUNORUBICIN, Leukemia, 12(2), 1998, pp. 144-149
Authors:
TODESCHINI G
MENEGHINI V
CANTINI M
SECCHI S
TECCHIO C
GRASSI A
VENERI D
AMBROSETTI A
SCOGNAMIGLIO F
PIZZOLO G
PERONA G
Citation: G. Todeschini et al., RETREATMENT OF ADULT ALL PATIENTS RELAPSED EARLY AFTER AN INTENSIVE FIRST LINE THERAPY, Blood, 90(10), 1997, pp. 3795-3795
Authors:
TODESCHINI G
TECCHIO C
MENEGHINI V
PIZZOLO G
VENERI D
ZANOTTI R
RICETTI MM
SOLERO P
APRILI F
PERONA G
Citation: G. Todeschini et al., THERAPEUTIC RESULTS IN 60 CONSECUTIVE ADULT PATIENTS AFFECTED BY ACUTE LYMPHOBLASTIC-LEUKEMIA (PROTOCOL ALLVR589), Blood, 90(10), 1997, pp. 3796-3796
Authors:
PASINI F
BASSETTO MA
TODESCHINI G
DIMARCO A
VERLATO G
SCOGNAMIGLIO F
ZANOTTI R
VENERI D
CETTO GL
AMBROSETTI A
Citation: F. Pasini et al., PRIMARY EXTRANODAL LYMPHOMAS OF WALDEYERS RING, STAGE IE AND IIE - LONG-TERM SURVIVAL AFTER CHEMOTHERAPY COMBINED WITH RADIOTHERAPY, International journal of oncology, 9(4), 1996, pp. 777-780
Authors:
GOTTARDI D
ALFARANO A
DELEO AM
STACCHINI A
ARAGNO M
RIGO A
VENERI D
ZANOTTI R
PIZZOLO G
CALIGARISCAPPIO F
Citation: D. Gottardi et al., IN LEUKEMIC CD5(-CELLS THE EXPRESSION OF BCL-2 GENE FAMILY IS SHIFTEDTOWARD PROTECTION FROM APOPTOSIS() B), British Journal of Haematology, 94(4), 1996, pp. 612-618
Authors:
TODESCHINI G
TECCHIO C
MENEGHINI V
PIZZOLO G
KRAMPERA M
AMBROSETTI A
VENERI D
NADALI G
FRANCHINI M
PERONA G
Citation: G. Todeschini et al., ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN ELDERLY PATIENTS RECEIVING INTENSIVE TREATMENT - EXPERIENCE IN 26 CONSECUTIVE PATIENTS, Blood, 88(10), 1996, pp. 3407-3407
Authors:
TODESCHINI G
TECCHIO C
MENEGHINI V
PIZZOLO G
SCOGNAMIGLIO F
AMBROSETTI A
ZANOTTI R
VENERI D
DEGANI D
FRANCHINI M
PERONA G
Citation: G. Todeschini et al., IMPROVED RESULTS IN 50 CONSECUTIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIAPATIENTS WITH VERY HIGH DOSAGE OF DAUNORUBICIN IN INDUCTION (PROTOCOLALL VR589), Blood, 86(10), 1995, pp. 2060-2060
Authors:
AMBROSETTI A
KRAMPERA M
VENERI D
MENEGHINI V
APRILI F
MARTINELLI G
PIZZOLO G
PERONA G
Citation: A. Ambrosetti et al., EARLY LYMPHOID BLASTIC CRISIS FOLLOWING MAJOR KARYOTYPIC CONVERSION IN A CHRONIC MYELOID-LEUKEMIA PATIENT TREATED WITH INTERFERON-ALPHA, International journal of clinical & laboratory research, 24(1), 1994, pp. 58-59
Authors:
PIZZOLO G
VINCENZI C
NADALI G
VENERI D
VINANTE F
CHILOSI M
BASSO G
CONNELLY MC
JANOSSY G
Citation: G. Pizzolo et al., DETECTION OF MEMBRANE AND INTRACELLULAR ANTIGENS BY FLOW-CYTOMETRY FOLLOWING ORTHO PERMEAFIX(TM) FIXATION, Leukemia, 8(4), 1994, pp. 672-676
Authors:
TODESCHINI G
MENEGHINI V
PIZZOLO G
CASSIBBA V
AMBROSETTI A
VENERI D
NADALI G
ZANOTTI R
TECCHIO C
PERONA G
Citation: G. Todeschini et al., RELATIONSHIP BETWEEN DAUNORUBICIN DOSAGE DELIVERED DURING INDUCTION THERAPY AND OUTCOME IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 8(3), 1994, pp. 376-381
Authors:
NADALI G
VINANTE F
AMBROSETTI A
TODESCHINI G
VENERI D
ZANOTTI R
MENEGHINI V
RICETTI MM
BENEDETTI F
VASSANELLI A
PERONA G
CHILOSI M
MENESTRINA F
FIACCHINI M
STEIN H
PIZZOLO G
Citation: G. Nadali et al., SERUM LEVELS OF SOLUBLE CD30 ARE ELEVATED IN THE MAJORITY OF UNTREATED PATIENTS WITH HODGKINS-DISEASE AND CORRELATE WITH CLINICAL-FEATURES AND PROGNOSIS, Journal of clinical oncology, 12(4), 1994, pp. 793-797
Authors:
VINANTE F
MOROSATO L
SIVIERO F
NADALI G
RIGO A
VENERI D
DESABATA D
VINCENZI C
CHILOSI M
SEMENZATO G
PIZZOLO G
Citation: F. Vinante et al., SOLUBLE FORMS OF P55-IL-2R-ALPHA, CD8, AND CD30 MOLECULES AS MARKERS OF LYMPHOID-CELL ACTIVATION IN INFECTIOUS-MONONUCLEOSIS, Haematologica, 79(5), 1994, pp. 413-419
Authors:
VINANTE F
MOROSATO L
SIVIERO F
NADALI G
RIGO A
VENERI D
DESABATA D
VINCENZI C
CHILOSI M
SEMENZATO G
PIZZOLO G
Citation: F. Vinante et al., SOLUBLE FORMS OF P55-IL-2R-ALPHA, CD8, AND CD30 MOLECULES AS MARKERS OF LYMPHOID-CELL ACTIVATION IN INFECTIOUS-MONONUCLEOSIS, Haematologica, 79(5), 1994, pp. 413-419
Authors:
TODESCHINI G
TECCHIO C
MENEGHINI V
PIZZOLO G
AMBROSETTI A
VENERI D
ZANOTTI R
PERONA G
Citation: G. Todeschini et al., HIGH-DOSE DAUNORUBICIN (DNM) IN INDUCTION OF ADULT ALL PATIENTS - PRELIMINARY-RESULTS OF A PILOT PROTOCOL (ALLVR589), Blood, 84(10), 1994, pp. 10000044-10000044
Authors:
TODESCHINI G
TECCHIO C
DEGANI D
PIZZOLO G
NADALI G
MARRADI P
PASINI F
CETTO GL
VENERI D
PERONA G
Citation: G. Todeschini et al., ANAPLASTIC LARGE-CELL LYMPHOMA CD30- CLINICAL-FEATURES AND LONG-TERM RESPONSE IN 40 CONSECUTIVE PATIENTS( (ALCL) ), Blood, 84(10), 1994, pp. 10000165-10000165
Authors:
TODESCHINI G
AMBROSETTI A
TECCHIO C
PIZZOLO G
MENEGHINI V
VENERI D
GIOVANNINI M
MENESTRINA F
PINTO F
FRANCHINI M
PERONA G
Citation: G. Todeschini et al., 3RD-GENERATION REGIMENS ARE THE THERAPY OF CHOICE IN PATIENTS WITH MEDIASTINAL LARGE B-CELL LYMPHOMA (MLBCL) WITH SCLEROSIS, Blood, 84(10), 1994, pp. 10000165-10000165
Authors:
AMBROSETTI A
NADALI G
VINANTE F
CARLINI S
VENERI D
TODESCHINI G
MOROSATO L
DESABATA D
CHILOSI M
MAGGI E
PARRONCHI P
ROMAGNANI S
SEMENZATO G
PERONA G
PIZZOLO G
Citation: A. Ambrosetti et al., SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN HODGKIN DISEASE - RELATIONSHIP WITH CLINICAL STAGE, TUMOR BURDEN, AND TREATMENT OUTCOME, Cancer, 72(1), 1993, pp. 201-206